Up a level |
(2022) Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial. Phytotherapy Research. pp. 1023-1031. ISSN 0951-418X